Astrana Health, Inc. Financial Ratios — ASTH Stock

Profitability (USD)

	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	01/31/2013	01/31/2014	03/31/2014	03/31/2015	03/31/2016	03/31/2017	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	6.36	7.59	-9.09	17.7	9.12	10.5	6.5	3.01
Return on Assets (%)	-388.24	-139.79	- -	-14.73	-54.07	-44.61	10.09	2.16	2.27	-3.07	8.18	4.93	6.39	3.77	1.26
Return on Capital (%)	- -	- -	- -	- -	- -	- -	3.32	-10.01	2.66	-7.15	13.4	6.51	9.73	6.62	3.91
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	19.49	17.3	4.47	-0.03	8.18	7.32	7.15	6.43	3.64
Gross Margin (%)	18.77	13.43	- -	33.11	22.81	15.14	23.26	30.54	16.56	5.86	22.97	17.43	15.5	13.34	10.73
EBITDA Margin (%)	-26.46	-36.99	- -	-1.09	-15.7	-17.22	15.9	21.45	9.4	6.6	14.95	10.65	7.38	5.76	3.91
Operating Margin (%)	-26.73	-37.29	- -	-2.1	-16.5	-18.35	10.55	17.74	6.14	1.64	12.69	9.11	6.1	4.39	2.47
Incremental Operating Margin (%)	- -	- -	-37.29	- -	- -	- -	16.1	33.42	-142.02	14.88	22.81	1.64	-8.1	0.73	-0.94
Pretax Margin (%)	-114.45	-43.3	- -	-3.59	-18.72	-15.2	13.95	15.89	4.61	2.4	10.05	7.57	6.48	3.97	1.24
Profit Margin (%)	-114.51	-47.88	- -	-5.46	-21.21	-15.62	7.24	2.08	2.52	-6.42	8.91	3.95	4.38	2.12	0.71
Net Income to Common Margin (%)	-114.51	-47.88	- -	-5.46	-21.21	-15.62	7.24	2.08	2.52	-6.42	8.91	3.95	4.38	2.12	0.71
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	7.82	27.06	31.61	103.54	40.76	47.19	35.61	38.22	39.21
Dvd Payout Ratio (%)	-4.49	-5.86	- -	-67.17	- -	- -	15.87	16.19	290.71	221.93	134.08	30.3	112.9	7.12	30.72
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	5.33	-14.47	11.09	-6.03	6.36	-1.35	6.04	2.09

Credit (USD)

Credit Ratios API ChatGPT

	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	01/31/2013	01/31/2014	03/31/2014	03/31/2015	03/31/2016	03/31/2017	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	3	4	7	9	- -	10	6	14	257	261	201	229	321	471	1,078
ST Debt	1	3	- -	1	- -	5	6	- -	13	14	4	5	25	15	56
LT Debt	2	1	6	8	- -	5	1	14	244	246	197	225	296	456	1,022
Total Debt/EBITDA	-1.22	-1.1	- -	-25.16	-0.03	-1	0.11	0.12	4.87	10.66	1.74	1.88	3.14	4.01	8.68
Net Debt/EBITDA	-0.65	-0.73	- -	-11.23	1.31	-0.12	-1.66	-0.84	2.63	1.95	-0.43	-0.69	-0.15	1.25	4.9
Total Debt/EBIT	-1.2	-1.09	- -	-13.04	-0.03	-0.94	0.17	0.15	7.45	42.81	2.05	2.2	3.79	5.27	13.73
Net Debt/EBIT	-0.64	-0.72	- -	-5.82	1.25	-0.12	-2.51	-1.02	4.02	7.83	-0.5	-0.81	-0.18	1.64	7.76
EBITDA to Interest Expense	-2.21	-5.71	- -	-0.27	-12.75	-119.31	710.93	198.81	11.13	9.67	21.45	15.38	6.36	3.54	2.49
EBITDA-CapEx/Interest Expense	-2.26	-5.74	- -	-0.3	-13.23	-122.9	684.77	196.73	10.91	9.21	17.89	12.48	4.59	3.3	2.29
EBIT to Interest Expense	-2.23	-5.76	- -	-0.52	-13.4	-127.1	471.56	164.4	7.27	2.41	18.2	13.16	5.25	2.7	1.57
Interest Expense	1	1	- -	1	1	- -	- -	1	5	3	5	8	16	33	50
Common Equity/Total Assets	-11.01	-66.14	-12.81	-18.79	-26.34	-54.82	32.6	35.19	26.29	40.47	51.67	56.15	65.81	52.6	35.12
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	1,849.33	0.18	3.32	67.57	55.35	38.6	40.21	72.12	88.68	183.13
Long-Term Debt/Capital (%)	90.37	42.55	122.97	95.35	- -	49.2	0.18	3.22	39.5	34.91	27.7	28.5	40.48	46.3	62.48
Long-Term Debt/Total Assets (%)	59.25	27.79	66.51	51.3	- -	24.22	0.13	2.63	33.48	30.14	22.72	23.24	31.74	33.65	46.08
Total Debt/Equity (%)	-639.91	-252.8	-416	-914.66	2.21	3,658.53	1.86	3.36	71.06	58.53	39.36	41.06	78.15	91.54	193.1
Total Debt/Capital (%)	118.52	165.44	131.65	112.28	2.16	97.34	1.83	3.25	41.54	36.92	28.24	29.11	43.87	47.79	65.88
Total Debt/Total Assets (%)	77.7	108.07	71.2	60.4	0.96	47.91	1.27	2.66	35.21	31.87	23.17	23.74	34.39	34.74	48.59
Net Debt to Equity	-339.25	-167.06	4.88	-408.26	-106.2	453.93	-28.01	-23.08	38.35	10.7	-9.67	-15.04	-3.74	28.44	109.13
Net Debt/Capital (%)	141.8	249.13	4.65	132.44	1,713.57	81.95	-38.8	-29.94	26.92	9.3	-10.32	-16.81	-3.51	21	50.48
EBITDA	-2	-4	- -	- -	-7	-10	57	112	53	24	116	122	102	117	124
EBITDA-CapEx	-2	-4	- -	- -	-7	-10	55	110	52	23	96	99	74	109	114
Operating Income (Loss)	-2	-4	- -	-1	-7	-11	38	92	34	6	98	104	85	89	79

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	01/31/2013	01/31/2014	03/31/2014	03/31/2015	03/31/2016	03/31/2017	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.69	0.32	2.79	0.84	1.25	0.6	0.92	1.5	2.08	2.27	2.5	1.98	1.36	0.8	0.7
Current Ratio	1.68	0.68	3.45	1.65	1.82	1.03	1.32	2.4	3.12	2.94	3.53	2.88	2.11	1.75	1.4
Quick Ratio	1.62	0.65	3.42	1.52	1.78	1.01	1.1	2.3	3.02	2.8	3.36	2.78	2.03	1.68	1.36
CFO/Avg Current Liab	0.04	-0.47	- -	-0.06	-0.27	-0.74	0.84	0.28	0.15	0.42	0.61	0.62	0.37	0.18	0.23
Common Equity/Total Assets	-11.01	-66.14	-12.81	-18.79	-26.34	-54.82	32.6	35.19	26.29	40.47	51.67	56.15	65.81	52.6	35.12
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	1,849.33	0.18	3.32	67.57	55.35	38.6	40.21	72.12	88.68	183.13
Long-Term Debt/Capital (%)	90.37	42.55	122.97	95.35	- -	49.2	0.18	3.22	39.5	34.91	27.7	28.5	40.48	46.3	62.48
Long-Term Debt/Total Assets (%)	59.25	27.79	66.51	51.3	- -	24.22	0.13	2.63	33.48	30.14	22.72	23.24	31.74	33.65	46.08
Total Debt/Equity (%)	-639.91	-252.8	-416	-914.66	2.21	3,658.53	1.86	3.36	71.06	58.53	39.36	41.06	78.15	91.54	193.1
Total Debt/Capital (%)	118.52	165.44	131.65	112.28	2.16	97.34	1.83	3.25	41.54	36.92	28.24	29.11	43.87	47.79	65.88
Total Debt/Total Assets (%)	77.7	108.07	71.2	60.4	0.96	47.91	1.27	2.66	35.21	31.87	23.17	23.74	34.39	34.74	48.59
CFO/Total Liabilities	1.6	-26.15	- -	-1.7	-16.7	-39.95	33.59	23.98	3.72	12.4	19.72	20.15	13.06	6.21	6.9
CFO/CapEx	1.27	-64.46	- -	-6.11	-7.02	-27.35	24.86	21.79	13.12	39.66	3.66	3.58	2.39	6.5	11.34
Altman's Z-Score	-0.47	-5.43	-0.3	1.64	1.08	-0.13	5.67	7.91	3.63	2.78	8.56	5.38	6	4.82	4.29

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	01/31/2013	01/31/2014	03/31/2014	03/31/2015	03/31/2016	03/31/2017	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	6.04	6.78	- -	12.43	12.25	12.91	54.37	67.8	59.84	41	87.62	37.99	21.94	11.53	9.78
Days Sales Outstanding	60.47	53.82	- -	29.38	29.81	28.28	6.71	5.38	6.1	8.9	4.17	9.61	16.64	31.64	37.31
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	25.03	21.05	- -	20.04	19.92	17.39	18.95	24.26	82.1	42.33	79.13	118.19	119.88	145.46	94.66
Accounts Payable Turnover Days	14.58	17.34	- -	18.21	18.33	20.99	19.26	15.04	4.45	8.62	4.61	3.09	3.04	2.51	3.86
Cash Conversion Cycle	45.89	36.48	- -	11.16	11.48	7.29	-12.54	-9.66	1.65	0.28	-0.45	6.52	13.59	29.13	33.45
Inventory to Cash Days	60.47	53.82	- -	29.38	29.81	28.28	6.71	5.38	6.1	8.9	4.17	9.61	16.64	31.64	37.31
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	01/31/2013	01/31/2014	03/31/2014	03/31/2015	03/31/2016	03/31/2017	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	22	25	27	24	35	54	775	686	661	772	3,279	1,378	1,794	1,511	1,213
- Cash & Cash Equivalents	1	1	7	5	9	9	100	107	103	193	233	288	294	288	429
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	11	11	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	1	- -	2	3	1	176	226	170	114	62	16	-203	-199	-221
+ Total Debt	3	4	7	9	- -	10	6	14	257	261	201	229	321	471	1,078
Enterprise Value	23	29	27	30	39	67	857	818	867	886	3,256	1,330	1,615	1,493	1,641
Total Capital	2	3	5	8	9	10	343	420	618	706	712	788	732	985	1,636
Total Debt/Capital (%)	118.52	165.44	131.65	112.28	2.16	97.34	1.83	3.25	41.54	36.92	28.24	29.11	43.87	47.79	65.88
Total Debt / EV	0.11	0.15	0.25	0.3	- -	0.15	0.01	0.02	0.3	0.29	0.06	0.17	0.2	0.32	0.66
EV/Sales	2.99	2.78	- -	0.92	0.9	1.17	2.41	1.57	1.55	2.39	4.21	1.16	1.16	0.73	0.52
EV/EBITDA	- -	- -	- -	- -	- -	- -	15.13	7.34	16.46	36.24	28.15	10.92	15.78	12.73	13.2
EV/EBIT	- -	- -	- -	- -	- -	- -	22.81	8.87	25.2	145.52	33.17	12.76	19.09	16.7	20.89
EV/Cash Flow to Firm	23.51	- -	- -	24.38	- -	- -	16.51	31.58	51.3	19.22	44.29	15.41	20.55	20.55	11.32
EV/Free Cash Flow to Firm	22.47	- -	- -	23.54	- -	- -	15.87	30.22	48.32	18.75	35.11	12.17	15.08	18.5	10.58
Diluted Market Cap	22	25	- -	24	35	54	775	753	670	685	3,330	1,344	1,803	1,512	1,225
Diluted Enterprise Value	23	29	- -	30	39	67	858	885	993	866	3,360	1,301	1,626	1,495	1,653
EV per Share	6.67	6.2	5.4	6.21	6.72	11.12	26.53	23.66	24.16	20.96	72.96	28.55	34.48	31.14	33.56
TTM Sales	8	10	- -	33	44	57	356	520	561	370	774	1,144	1,387	2,035	3,182
TTM EBITDA	-2	-4	- -	- -	-7	-10	57	112	53	24	116	122	102	117	124
TTM Operating Income	-2	-4	- -	-1	-7	-11	38	92	34	6	98	104	85	89	79
TTM Cash Flow to Firm	1	-1	- -	1	-1	-8	52	26	17	46	74	86	79	73	145
TTM Free Cash Flow to Firm	1	-1	- -	1	-1	-8	54	27	18	47	93	109	107	81	155

Multiples (USD)

Valuation Multiples API ChatGPT

	2013 Y	2014 Y	2014 Y	2015 Y	2016 Y	2017 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	01/31/2013	01/31/2014	03/31/2014	03/31/2015	03/31/2016	03/31/2017	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	211.57	-17.42	- -	-106.93	-22.1	-6.92	14.38	28.22	45.54	14.47	37.18	12.79	18.63	25.1	9.82
EV/EBIT	- -	- -	- -	- -	- -	- -	22.81	8.87	25.2	145.52	33.17	12.76	19.09	16.7	20.89
Enterprise Value	23	29	27	30	39	67	857	818	867	886	3,256	1,330	1,615	1,493	1,641
Low Price	0.8	2.1	2.6	2.5	3.75	1.41	5.65	13.01	13.02	9.27	18.26	26.89	27.55	31.34	20.12
EV/Sales	2.99	2.78	- -	0.92	0.9	1.17	2.41	1.57	1.55	2.39	4.21	1.16	1.16	0.73	0.52
EV/EBITDA	- -	- -	- -	- -	- -	- -	15.13	7.34	16.46	36.24	28.15	10.92	15.78	12.73	13.2
Price/Earnings	- -	- -	- -	- -	- -	- -	30.05	60.26	45.27	- -	46.59	29.48	29.46	34.65	54.15
Price/Earnings Average	-1.51	-5.35	- -	-12.98	-3.95	-4.05	12.4	58.85	43.62	-25.8	36.48	41.72	26.36	48.24	62.67
Price/Earnings High	-5.4	-7.01	- -	-18.89	-6.29	-6.89	31.3	91.08	57.19	-30.17	84.48	73.73	31.39	69.45	87.23
Price/Earnings Low	-0.31	-1.96	- -	-6.74	-2.36	-0.95	7.07	39.5	32.01	-14.21	11.58	26.79	21.19	34.44	43.91
Price/Book Value	-61.86	-9.68	-22.24	-8.63	-6.76	-4.8	4.85	3.8	3.45	2.33	7.32	2.54	2.92	2.12	1.56
Price/Book Value Average	-38	-10.26	-22.83	-8.31	-7.16	-3.21	2	3.71	3.33	2.15	5.73	3.6	2.61	2.95	1.8
Price/Book Value High	-135.5	-13.44	-30.33	-12.08	-11.4	-5.46	5.05	5.75	4.36	2.51	13.27	6.35	3.11	4.25	2.51
Price/Book Value Low	-7.85	-3.76	-10.51	-4.32	-4.28	-0.75	1.14	2.49	2.44	1.18	1.82	2.31	2.1	2.11	1.26
Price/Tangible Book Value	-56.56	-7.98	-15.27	-3.82	-3.82	-3.66	-5.81	-7.45	-4.41	161.28	27.57	7.01	6.8	8.62	-3.4
Price/Tangible Book Value Average	-34.75	-8.46	-15.68	-3.68	-4.04	-2.45	-2.4	-7.28	-4.25	148.55	21.59	9.92	6.09	12	-3.93
Price/Tangible Book Value High	-123.9	-11.09	-20.83	-5.35	-6.44	-4.17	-6.05	-11.26	-5.57	173.73	49.99	17.53	7.25	17.28	-5.47
Price/Tangible Book Value Low	-7.18	-3.1	-7.22	-1.91	-2.41	-0.57	-1.37	-4.88	-3.12	81.83	6.85	6.37	4.89	8.57	-2.76
Price/Sales	2.82	2.42	- -	0.74	0.79	0.95	2.18	1.26	1.14	1.8	4.15	1.16	1.29	0.73	0.38
Price/Sales Average	1.73	2.56	- -	0.71	0.84	0.63	0.9	1.23	1.1	1.65	3.25	1.65	1.15	1.02	0.44
Price/Sales High	6.18	3.36	- -	1.03	1.33	1.08	2.27	1.9	1.44	1.94	7.52	2.91	1.37	1.47	0.62
Price/Sales Low	0.36	0.94	- -	0.37	0.5	0.15	0.51	0.82	0.81	0.91	1.03	1.06	0.93	0.73	0.31
Price/Cash Flow	378.76	-17.15	- -	-89.43	-18.95	-6.67	14.96	25.61	46.73	14.41	45.66	16.21	26.22	28.64	10.62
Price/Cash Flow Average	232.7	-18.18	- -	-86.07	-20.07	-4.46	6.17	25.01	45.03	13.27	35.75	22.95	23.46	39.88	12.3
Price/Cash Flow High	829.66	-23.82	- -	-125.2	-31.95	-7.6	15.58	38.7	59.04	15.52	82.78	40.55	27.94	57.41	17.12
Price/Cash Flow Low	48.1	-6.67	- -	-44.72	-11.98	-1.05	3.52	16.78	33.05	7.31	11.35	14.73	18.86	28.47	8.62
Price/Free Cash Flow Average	129.98	-18.46	- -	-102.91	-23.41	-4.63	5.93	27.56	43.89	13.33	29.11	18.1	16.67	34.94	11.37
Price/Free Cash Flow High	463.44	-24.2	- -	-149.71	-37.27	-7.89	14.98	42.66	57.54	15.59	67.41	31.99	19.85	50.31	15.82
Price/Free Cash Flow Low	26.87	-6.78	- -	-53.47	-13.97	-1.08	3.39	18.5	32.21	7.34	9.24	11.62	13.4	24.95	7.97
EV/Sales Average	1.9	2.92	- -	0.89	0.94	0.86	1.13	1.54	1.71	2.41	3.36	1.67	1.03	1.03	0.58
EV/Sales High	6.35	3.72	- -	1.21	1.44	1.3	2.5	2.25	2.07	2.74	7.72	2.98	1.25	1.48	0.75
EV/Sales Low	0.52	1.3	- -	0.55	0.61	0.37	0.74	1.12	1.41	1.55	1.09	1.06	0.8	0.73	0.44
EV/EBITDA Average	-7.18	-7.9	- -	-81.33	-6.01	-4.97	7.11	7.2	18.22	36.52	22.45	15.66	13.96	17.8	14.74
EV/EBITDA High	-24	-10.05	- -	-110.9	-9.17	-7.55	15.72	10.49	21.98	41.45	51.66	27.95	16.95	25.69	19.16
EV/EBITDA Low	-1.98	-3.51	- -	-50.09	-3.86	-2.16	4.68	5.22	15	23.45	7.31	9.93	10.89	12.67	11.36
EV/EBIT Average	-7.11	-7.83	- -	-42.16	-5.72	-4.66	10.72	8.71	27.89	146.63	26.46	18.3	16.89	23.36	23.32
EV/EBIT High	-23.76	-9.97	- -	-57.48	-8.72	-7.09	23.7	12.69	33.65	166.43	60.87	32.65	20.51	33.72	30.33
EV/EBIT Low	-1.96	-3.48	- -	-25.97	-3.67	-2.02	7.06	6.32	22.97	94.16	8.61	11.6	13.17	16.63	17.97
Last Price	6.3	5.4	5.5	5	5.93	9	24	19.85	18.41	18.27	73.48	29.59	38.3	31.53	24.81
High Price	13.8	7.5	7.5	7	10	10.25	25	30	23.26	19.68	133.23	74.01	40.81	63.2	39.97
Enterprise Value Average	15	31	27	29	42	49	403	803	960	892	2,598	1,908	1,429	2,088	1,831
Enterprise Value High	49	39	36	40	63	75	890	1,170	1,158	1,013	5,977	3,404	1,735	3,013	2,382
Enterprise Value Low	4	14	12	18	27	21	265	583	790	573	845	1,210	1,114	1,486	1,411

Shares Outstanding	3	5	5	5	6	6	32	35	36	42	45	47	47	48	49
Diluted Weighted Avg Shares	3	5	- -	5	6	6	32	38	36	37	45	45	47	48	49
Basic Weighted Avg Shares	3	5	- -	5	6	6	32	33	35	36	44	45	47	47	49
Revenue per Share	2.23	2.23	- -	6.78	7.5	9.52	11.03	15.81	16.15	10.17	17.71	25.43	29.69	42.91	64.83
EBITDA per Share	-0.59	-0.83	- -	-0.07	-1.18	-1.64	1.75	3.39	1.52	0.67	2.65	2.71	2.19	2.47	2.53
Operating Income per Share	-0.6	-0.83	- -	-0.14	-1.24	-1.75	1.16	2.8	0.99	0.17	2.25	2.32	1.81	1.88	1.6
Basic EPS, GAAP	-2.56	-1.07	- -	-0.37	-1.59	-1.49	0.8	0.33	0.41	-0.65	1.58	1	1.3	0.91	0.46
Basic EPS from Cont Ops	-2.56	-0.97	- -	-0.28	-1.39	-1.44	1.42	1.83	0.51	-0.01	1.05	1.02	1.24	1.05	0.49
Diluted EPS, GAAP	-2.56	-1.07	- -	-0.37	-1.59	-1.49	0.8	0.29	0.39	-0.63	1.52	0.99	1.29	0.9	0.46
Diluted EPS from Cont Ops	-2.56	-0.97	- -	-0.28	-1.39	-1.44	1.42	1.59	0.49	-0.01	1.02	1.01	1.23	1.04	0.49
Dividend per Share	0.11	0.05	- -	0.12	- -	- -	0.32	0.54	1.78	1.41	0.71	0.31	1.33	0.09	0.16
Cash Flow per Share	0.02	-0.31	- -	-0.06	-0.31	-1.35	1.6	0.78	0.39	1.27	1.61	1.83	1.46	1.1	2.34
Free Cash Flow per Basic Share	- -	-0.32	- -	-0.07	-0.36	-1.4	1.54	0.74	0.36	1.24	1.17	1.32	0.85	0.93	2.13
Cash & Equivalents per Share	0.34	0.31	1.39	1.03	1.58	1.44	3.12	3.12	6.12	6.18	6.42	6.3	6.33	6.07	8.79
Book Value per Share	-0.1	-0.56	-0.25	-0.58	-0.88	-1.88	4.95	5.22	5.33	7.83	10.04	11.65	13.11	14.87	15.94
Tangible Book Value per Share	-0.11	-0.68	-0.36	-1.31	-1.55	-2.46	-4.13	-2.66	-4.18	0.11	2.67	4.22	5.63	3.66	-7.3

Astrana Health, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)